Loading...
OTCM
CANSF
Market cap31mUSD
Jul 09, Last price  
0.09USD
1Q
-26.23%
Jan 2017
2,150.00%
IPO
-17.43%
Name

Willow Biosciences Inc

Chart & Performance

D1W1MN
OTCM:CANSF chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
33.73%
Rev. gr., 5y
299.45%
Revenues
0k
-100.00%
00000000000016,9134,58410,000133,000821,0001,172,0004,662,0000
Net income
-3m
L-58.19%
-404,409-1,652,348-1,152,053-3,057,264-3,216,858-1,417,000-1,801,000-1,387,172-865,372-1,311,000-2,330,000-1,857,000-1,645,000-44,566,000-33,946,000-6,140,000-14,814,000-13,029,000-6,189,000-2,587,889
CFO
0k
P
-211,791-1,105,101-922,612-889,158-865,764-564,695-96,042-921,187-614,451-433,340-1,280,663-537,685-1,333,084-9,161,395-12,780,000-18,227,000-13,862,000-10,920,000-3,723,0000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Atlas Energy Corp. is a biotechnology firm established in 2019 and headquartered in Calgary, Canada. The company specializes in the creation, manufacturing, and distribution of plant-based ingredients, primarily catering to the consumer care, food and beverage, and pharmaceutical industries throughout the United States. Atlas Energy Corp. maintains a strategic licensing and development partnership with Laurus Labs, focusing on the advancement and commercialization of active pharmaceutical ingredients and various other compounds. The company, previously known as Willow Biosciences Inc., officially adopted the name Atlas Energy Corp. in June 2025.
IPO date
Sep 14, 2017
Employees
32
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT